Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
APGE
APGE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
APGE News
Apogee Therapeutics CEO Sells 20,000 Shares of Stock
4d ago
Fool
Apogee Therapeutics Prices Public Offering at $70 per Share
5d ago
Newsfilter
Apogee Therapeutics Prices Upsized Public Offering of 5M Shares
5d ago
seekingalpha
Apogee Therapeutics Successfully Prices Public Offering
6d ago
Yahoo Finance
Apogee Therapeutics Launches $300 Million Public Offering
6d ago
NASDAQ.COM
US Stocks Surge as Oil Prices Plunge Over 10%
Mar 23 2026
NASDAQ.COM
Apogee Therapeutics Launches $300 Million Public Offering
Mar 23 2026
seekingalpha
Oil Price Plunge Boosts Stock Market Gains
Mar 23 2026
NASDAQ.COM
Stock Market Rises as Oil Prices Plunge
Mar 23 2026
NASDAQ.COM
Apogee's Zumilokibart Shows Promising Phase 2 Results for Eczema Treatment
Mar 23 2026
NASDAQ.COM
Biotech Stock Rises Sharply Following Encouraging Trial Outcomes
Mar 23 2026
stocktwits
Apogee Therapeutics Reports Positive Phase 2 APEX Data for Zumilokibart
Mar 23 2026
seekingalpha
Apogee Stock Rises 16.6% in Premarket Following Positive Mid-Stage Trial Results for Eczema Drug
Mar 23 2026
moomoo
APOGEE THERAPEUTICS INC - ZUMILOKIBART SHOWS GOOD TOLERABILITY AND SAFETY PROFILE SIMILAR TO OTHER DRUGS IN ITS CLASS
Mar 23 2026
moomoo
APOGEE THERAPEUTICS INC - ENHANCED RESPONSE NOTED IN LESIONAL AND ITCH MEASURES AFTER 3 AND 6 MONTHS OF TREATMENT
Mar 23 2026
moomoo
Apogee Therapeutics Presents New Data on Zumilokibart in Phase 2 APEX Trial
Mar 23 2026
NASDAQ.COM
Show More News
